October 10, 2024 – New survey information from Premier, Inc. reveals that greater than 86 % of healthcare suppliers are experiencing a scarcity of IV fluids within the aftermath of Hurricane Helene. The shortages have been evenly distributed nationally throughout all forms of suppliers. In response to Premier, the shortages additionally appeared to have an equal influence on suppliers, no matter their measurement or system connection.

The provision of IV fluids was threatened for the primary time after the main producer with a greater than 60 % market share in the US suffered harm at its North Carolina plant on account of Hurricane Helene.

Of Premier survey respondents, 88 % report receiving fewer than half of their requested IV fluid orders. In consequence, roughly 54 % of respondents have 10 days or much less of IV fluids in inventory, in comparison with a extra typical 15 to 22 days of stock, based on historic buying and real-time ordering information from Premier, with restricted means to stockpile these inventories replenish. Smaller suppliers (these with 25 or fewer beds) have been extra seemingly than different supplier sorts to report receiving zero % of their ordered portions of IV fluids.

Given these tendencies, suppliers reported in qualitative survey feedback that it is just a matter of time earlier than provide dwindles to zero.

Given restricted product availability, practically 17 % of suppliers surveyed have canceled elective surgical procedures and different procedures, and one other 58 % are contemplating that possibility within the close to time period. Moreover, 78 % of suppliers report that they are going to be pressured to cancel procedures within the coming month if the state of affairs doesn’t enhance.

Learn Premier's full report right here.